Tackling the Burden and Shame of Hearing Loss

With a growing number of people expected to experience hearing loss in coming years, drugmakers and tech companies are angling to tackle the problem.

In 1983, The New York Times published a bombshell report about President Ronald Reagan: Starkey Laboratories had fitted the President, then 72, with a hearing aid. The news was welcomed by health professionals who reckoned it could help to reduce the stigma associated with hearing loss. At the time, one in three people over the age of 60 was thought to have hearing problems, though only around 20 percent who needed hearing aids used them.

“The way I do the math, a third of all adults have unaddressed hearing issues. That’s lot of people.”

Indeed, Reagan’s handlers knew too well that the revelation risked making the president look like a feeble old man — and worse, someone ill-equipped to run the most powerful nation on earth. “Among Presidential advisers,” The New York Times noted, “Mr. Reagan’s use of a hearing aid revived speculation on whether his age would be an issue if he seeks re-election next year.”

Reagan won re-election, of course, but nearly 40 years later, negative perceptions persist — and health advocates are more concerned than ever. Hearing loss, they say, is not just a functional disability affecting a subset of aging adults. With population growth and a boom in the global elderly population, the World Health Organization (WHO) now estimates that by 2050, more than 900 million people will have disabling hearing loss. A 2018 study of 3,316 children aged nine to 11 meanwhile, found that 14 percent already had signs of hearing loss themselves. While not conclusive, the study linked the loss to the rise of portable music players.

The problem is compounded by the fact that people with hearing loss are at greater risk for a host of other problems: social isolation, abuse, depression, lower overall incomes, restricted career choices, and occupational stress. A 2017 Lancet Commissions report named hearing loss as one of the largest potentially-modifiable risk factors for dementia, and the WHO estimates that unaddressed hearing loss comes with an annual global cost of at least $750 billion.

The crisis now has Starkey Hearing Technologies (the company changed its name in 2011) — and a growing and competitive field of scientists, drug developers, technology companies, and venture capitalists — angling to head-off the intertwined problems of hearing damage and cognitive decline. “Hearing loss has always been the poor step-sister of disabilities, and people still make fun of it,” said Karl Strom, editor in chief of the trade publication The Hearing Review.

“But it’s a serious disability,” he added “and has been linked to everything from cognitive function disabilities [such as] Alzheimer’s to depression and loneliness and a raft of comorbidities from diabetes to ischemic heart disease.”


Love Undark? Sign up for our newsletter!


And yet, just like Reagan’s worried handlers, the specter of hearing loss is still often greeted by many people with denial, shame, and reluctance to seek out solutions. The Hearing Loss Association of America reports that 48 million Americans currently have hearing loss, making it the third most common chronic ailment in the United States — ahead of diabetes and cancer, according the Centers for Disease Control and Prevention (CDC). The CDC also lists occupational hearing loss from noise exposure as the most common U.S. work-related illness. Despite that, the U.S. Food and Drug Administration (FDA) says only one-fifth of people who could benefit from a hearing aid seek it out.

Overcoming the sense of stigma is one of the main challenges facing researchers and technologists looking to curb hearing loss with new drugs, or to restore hearing in those who’ve lost it with a new generation of high-tech devices. Should they succeed, the payoff — both financial and social — is potentially huge.

“The way I do the math, a third of all adults have unaddressed hearing issues,” said Kevin Franck, audiology director at Massachusetts Eye and Ear, a Harvard-affiliated teaching and research hospital. “That’s lot of people.”


The inner ear is filled with thousands of microscopic hair cells. When sound waves hit these hair cells they vibrate, creating electrical signals that reach the brain through the auditory nerve. Today, hearing loss is attributed to a number of factors, including presbycusis, which can be caused by the natural cell deterioration that comes with aging. Noise-induced hearing loss, or NIHL, is also a major factor, as are medications that, as a side effect, can cause damage to the hairs of the inner ear.

While drug developers are focused on regeneration, hearing aid manufacturers are aiming to make their devices as indispensable as smartphones.

“If you are a venture capitalist,” Franck said, “you get very excited about those numbers.” But helping people who have experienced hearing loss “is not as easy as selling them an app or a pair of headphones,” he added. “It’s more complicated than that.”

One potential breakthrough may come from a handful of drugs currently being tested to combat hair cell damage from ototoxic drugs. Scores of medications used to treat everything from infections to cancer to heart disease can kill off these cells. Currently Boston-based Decibel Therapeutics has two drugs to counteract these side effects — small molecules administered via transtympanic injection or taken orally — in Phase I clinical trials.

“Cisplatin and aminoglycoside antibiotics are powerful drugs, which unfortunately often come at the expense of the delicate cells in the inner ear that are necessary for hearing and balance,” Decibel’s chief medical officer Peter Weber wrote in an email. “We hope to change the equation for clinicians and patients by preventing these medications from damaging the inner ear, without interfering with the lifesaving efficacy that they are known for.”

In Woburn, Massachusetts, Frequency Therapeutics has begun Phase I and II trials with a potentially broader solution. The company’s regeneration platform offers hope for those with NIHL, presbycusis, and other forms of hearing loss. Its process involves progenitor cell activation — in essence, coaxing cells back to their development phrase to get them to generate more hair cells.

“I’m a drug developer by trade and have been in the field for about 30 years and I’ve been pretty bearish on regenerative therapies,” Frequency Therapeutics chief development officer Carl LeBel said. But now, he says, the company can stimulate stem cells in the ear, which in turn regenerate the more specialized sensory cells. “Up until today no one has been able to crack the nut about how we can regenerate that function,” LeBel said. “That’s why we are so enthusiastic about our technology.”

LeBel sees the company’s platform as potentially applicable to multiple sclerosis, alopecia, muscle regeneration, and a wide swath of autoimmune diseases. But others caution against looking for miracles in the coming months. “For my entire career, they’ve been five years away,” Franck said.

“Something has happened where I do believe that, after these 20 some years I have been in the profession, they are closer,” he added. “But they always seem like they’re right over the horizon.”

While drug developers are focused on regeneration, hearing aid manufacturers are aiming to make their devices as indispensable as smartphones — not just for those with hearing impairments, but for everyone. Other functions, beyond improving hearing, “would make the non-hearing aid person jealous that they don’t have one,” said Bill Facteau, the president and CEO of the California-based hearing-aid developer Earlens. “That is going to be the game changer.”

Earlens developed technology to convert sound information into non-visible light that activates a lens on the eardrum to vibrate it, which the company claims conducts sound more efficiently. The innovation represents only a sliver of the advances hearing aids have made in the past few years. Many can now be connected to mobile devices to allow wearers to stream phone calls, TV programs, and music, while directional microphones can improve everyone’s hearing in crowded restaurants, on windy hikes, or at any noisy event.

At the higher end of the spectrum, these features can be fine-tuned with phone apps, some of which adapt to make automatic adjustments as the user moves from one type of noise environment to another.

The Arizona Hearing Center breaks down the basics of a new hearing aid called Earlens.

At Starkey Hearing Technologies, chief technology officer Achin Bhowmik helped to develop the Livio AI, which doubles as a FitBit-like health tracker, a fall detection sensor, and a language translator that transcribes speech to text on your phone, among other functions. The company also added brain-health features that track daily social engagement and active listening. Although at least one 2019 study linking losses in hearing and cognitive function failed to find social engagement as a factor in staving off mental decline, Bhowmik thinks this added functionality could help combat dementia and Alzheimer’s.

“Your FitBit or Apple Watch has no clue whether you are socially engaged,” Bhowmik said.

“It was a slam dunk for me to integrate those features into the hearing aid,” he added.

For all their efforts, Earlens, Starkey, and other industry players — Widex, Phonak, Oticon — may face new competition for their creations. In October, the FDA approved the first direct-to-consumer hearing aid, which unlike the standard audiologist-fitted device, can be fitted by the user. The product, developed by Bose, must still comply with federal and state laws relating to the sale of hearing aids, though the FDA is also currently drafting regulations for a new category of hearing aids that can be sold over the counter.

In October, the FDA approved the first direct-to-consumer hearing aid, which can be fitted by the user.

All of this is aimed at increasing access and reducing costs. As it stands, Medicare doesn’t cover hearing care or hearing aids, and the average price of a single aid comes in at around $2,400. High-end offerings often double that.

Bhowmik believes the ballooning number of customers and competitors will naturally drive down costs. “Look at the hearing aid market and 15 million hearing aids sold by the entire industry [per year],” he said. “Imagine a world where I can drive the volume up 10 times, and what I can do to the economics of them.”

For his part, Franck doesn’t know if treatment costs will come down fast enough to meet the rising need. But he does see the potential for a new generation of aging adults that won’t tolerate the once-thought-to-be inevitable decline that past generations accepted.

“They are going to demand greater performance from hearing for longer in their lives,” Franck said. “Some people take hearing loss as something that just happens when you get old. I think this generation might say, ‘I don’t care if I have to wear something on my ears, I’ve already been wearing stuff on my ears.’”


Whether that sort of shameless embrace of hearing-loss and hearing aids will come to pass, of course, remains an open question — not least because unease clearly persists.

“If president Clinton doesn’t want anyone to see his hearing aids, there still is some stigma.”

When Bhowmik joined Starkey Hearing Technologies in 2017, one of the few things he knew about the company was the legendary story of Reagan’s hearing aid. A veteran of Intel, where he was vice president and general manager of the perceptual computing group, Bhowmik quickly learned that innovations in the field of audiology rivaled anything happening in Silicon Valley. Scientists working on hearing loss had their fingers in everything from artificial intelligence to stem cell therapies.

But when former U.S. President Bill Clinton came to the company recently to be fitted with new hearing aids, Bhowmik also learned that pride remains a barrier to seeking help with hearing problems. During a visit with Clinton, Bhowmik says he showed him Starkey’s latest hearing aids. The devices come packed with radically-advanced technology — light years ahead of what Starkey had offered President Reagan decades earlier — but they remain too large to fit discreetly inside the ear.

Clinton wasn’t interested.

“He still likes to use our invisible, in-ear canal device nobody can see,” Bhowmik said. “If president Clinton doesn’t want anyone to see his hearing aids, there still is some stigma.”


Jed Gottlieb is a Massachusetts-based writer whose work has appeared in The Boston Herald, Newsweek, Fast Company, Billboard, Quartz, and the Columbia Journalism Review, among other publications.

Top visual: Hulton Archive via Getty
See What Others Are Saying

15 comments / Join the Discussion

    The cost of hearing aids is outrageous. Such a simple device should not cost $3500, as I paid. I was shown a chart with one set for $1700 and another for $5200. I was told that the best choice was the midrange priced pair. I found out later my mother- in- law was scammed the same way in the same audiology office.

    When has a medical device or drug recently gone down in price in the U.S.? Never believe a business person who ‘promises’ such a ludicrous proposition.

    Also, having tracking software in hearing aids is another opportunity for a business to know everything you do. Phones and the internet track our purchases and online history. Will businesses be able to hear what we hear and say? Let’s not give away the rest of our lives to corporate interests.

    Reply

    Good article that covered all the bases, but I do wish the author — and Kevin Franck — had mentioned the Hearing Loss Association of America, which is working hard with federal regulators and others to help bring the price of hearing aids down, to help make it easier to find a hearing-aid provider and get hearing aids, and to ensure compliance with the Americans with Disabilities ACT for people with hearing loss. HLAA was a significant contributor to the FDA’s discussion of over-the-counter hearing aids and continues to work with the FDA through the comment period before OTC aids go on the market. Through local chapters, including several in the Boston area, HLAA provides information, education and support for people with hearing loss. The letter writers below, especially the poor man suffering so from tinnitus, might find some new ways to deal with their disability. I serve on the HLAA board with Kevin Franck. Although the affiliation was probably lost in the editing, I’m sure Kevin would agree with me about the value of HLAA’s work nationally and locally.

    Reply

    I credit apple’s wireless earpods for normalizing hearing aids among the younger set. Those earpods look like in-ear hearing aids with twigs, varnished white. I’m sure the twigs serve as the mark of coolness right now. Meanwhile, I blend in with a sleek behind-the-ear silver model – no twigs, no wires. :)

    Reply

    Please don’t dispear. Things in the hearing loss world are getting better, I have a profound hearing loss and have learned so much to help myself. Fighting hearing loss is not totally dependent on hearing aids or cochlear implants. Fighting hearing loss really needs a three legged attack. Aids can not do it all. You also need strategy and technology. Neither of these are expensive and really cost little or even nothing. By strategy I am talking about things like where to sit in a restaurant to find the quietist spot or a way of having your spouse/partner learn and use something called Clear Speech. And some technology such as a new app for android phones called Live Transcribe that turns speech to text is FREE . Where did I learn most of this through the Hearing Loss Association of America. Seek out a local chapter. They even have a program called N-CHATT where a speaker can come and address your church or civic or other group on hearing loss ( I am in trading o be come one);Pleae Don’t dispear.

    Reply

    I think that the focus of this article is off base. Vanity is not the main deterrent for most people—it is the price. The decline in my hearing factored into my decision to retire, but as a retiree—with a pension and Social Security—most hearing aids are beyond my budget. Should I go into savings for something that may or may not actually help me with my particular hearing deficiency? These expensive little gadgets come with few guarantees. The great breakthrough that will make hearing aids costs hundred, not thousands, or dollars has been promised for at least five years. I am still waiting.

    Reply

    This is FASCINATING and incredibly encouraging, Undark, thank you! I hadn’t thought this kind of treatment would be available for the foreseeable future, and it’s nice to see it getting a step or two closer to reality.
    I can’t speak to the cost issues in the U.S., except to point out that hearing aids are easier to pay for here in Canada, and in any other country with universal health care coverage…in other words, every other industrialized country on the planet.
    BUT that’s not the comment I actually wanted to share, until I read the previous ones. Mine has to do with the stigma around hearing loss, and the frustration and social isolation that can go along with losing your hearing.
    The audiologist who first diagnosed my hearing loss about a decade ago was far more concerned with giving me aids that weren’t visible than with finding the model that would fit my hereditary pattern of deafness. Needless to say, my first step to getting the right aids was to find a new audiologist.
    But I appreciate that moment in retrospect, not only because I finally had a diagnosis, but because it got me thinking about how and why the stigma developed. We mostly accept that our eyesight will fail with time, and while I don’t have data for this, my impression is that most people who choose contact lenses over glasses do so for convenience, maybe for cosmetics, but certainly not out of a sense of shame.
    So why is it shameful to lose our hearing? Again, this is just speculation, but I think it’s because missing one or many beats in a conversation makes you look stupid, and that points back to the time when we used to talk about people being “deaf and dumb” (with “dumb” as a synonym for “mute”). I don’t think it’s impossible that we tend to confuse the two, and for many people who lose their hearing, the first impulse is to either deny it or hide out.
    I’ve found that it’s a lot more productive, and it *almost* always works, to let people know what’s going on and enlist their help. It usually lands well when I get a chance to suggest that, while there are a great many reasons to suspect me of being dumb, my deafness is not one of them.
    As recently as yesterday, I was giving a talk on a contentious, urgent topic where the details matter — climate change communication — in an open-concept space with a lot of background noise. I explained right off the top why I might have to ask people to repeat their questions, then got them to consistently shout their comments so that *other participants* across the room could hear. Being pro-active made me the canary in the coal mine for others who couldn’t hear parts of the session, either because they also had diagnosed or undiagnosed hearing loss, or just because the space was distracting and echoey.
    Once in a while, I’ll run into someone who gets dismissive or resentful that I can’t easily hear every supremely important word they utter. Usually, it’s easy enough to silently, politely decide that they’ve self-selected, and it really won’t be necessary to interact with them ever again. On the other hand, I’ve also learned that when I hear someone say something unexpectedly funny, it’s often because I didn’t quite hear what they actually said — and if I tell them what I heard, they can set me straight after we’ve both had a good laugh.

    Reply

    Pricing of hearing aids seems to be a price fixing racket. All the top brands are priced about the same for ‘premium’ aids. That makes no sense unless there is some sort of collusion.

    Reply

    This country should be ashamed of how little is done financially to help the hearing impaired. All the technology in the universe won’t help If average people can’t afford to access it.

    Reply

    I have bilateral hearing loss and bilateral tinnitus my hearing loss is significant but i would rather be deaf, than endure life destroying tinnitus which i have had for 28 years i take max dose antidepressants , valium and a bottle of wine a night just to get some sleep but my feelings towards T are very aversive so mine is just an existance if i could get euthanasia i would be first in the queue

    Reply

    And yet decades later, getting hearing aids is still beyond the grasp of folks that can’t shell out anywhere from $600 to $7000. Shame.

    Reply

    Yes this is a sad situation. My husband can’t hear a thing,my failing health I need to call on him when I fall. And he can’t even hear my screaming. Medicare needs to start paying for hearing services.

    Reply
Join the discussion

Your email address will not be published. Required fields are marked *

Top

Whistleblowers
& Tipsters

Corruption in science?
Academic discrimination?
Research censorship?
Government cover-ups?

Undark wants to hear about it.

Email us at tips@undark.org, or visit our contact page for more secure options.